Decreased expression of transforming growth factor-β1 and α-smooth muscle actin contributes to the protection of lotensin against chronic renal failure in rats

References

• Grupp C, Troche I, Klass C, et al. A novel model to study renal myofibroblast formation in vitro. Kidney Int. 2001;59:543–553. Feb doi: 10.1046/j.1523-1755.2001.059002543.x.
   PubMed Web of Science ®Google Scholar
• Ruiz-Ortega M, Ruperez M, Lorenzo O, et al. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl. 2002;62:S12–S22. Dec doi: 10.1046/j.1523-1755.62.s82.4.x.
   Google Scholar
• Schnaper HW, Hayashida T, Hubchak SC, et al. TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol. 2003;284:F243–F252. Feb doi: 10.1152/ajprenal.00300.2002.
   PubMed Web of Science ®Google Scholar
• Dai C, Liu Y. Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J Am Soc Nephrol. 2004;15:1402–1412. JunPubMed PMID: 15153551; eng.
   PubMed Web of Science ®Google Scholar
• Tsuchida K, Zhu Y, Siva S, et al. Role of Smad4 on TGF-beta-induced extracellular matrix stimulation in mesangial cells. Kidney Int. 2003;63:2000–2009. Jun doi: 10.1046/j.1523-1755.2003.00009.x.
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhou QS, Pi L, et al. Role of angiotensin II and JAK2 signal pathway in transdifferentation of renal tubular cells in mice after acute ischemic followed by reperfusion. Zhonghua Bing Li Xue Za Zhi 2009;38:466–471. Jul
   PubMedGoogle Scholar
• Dai C, Yang J, Bastacky S, et al. Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J Am Soc Nephrol. 2004;15:2637–2647. Oct doi: 10.1097/01.asn.0000139479.09658.ee.
   PubMed Web of Science ®Google Scholar
• Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol. 1985;249:F324–F337. Sep doi: 10.1152/ajprenal.1985.249.3.F324
   PubMed Web of Science ®Google Scholar
• Wang HY, Yang LZ, Cui MJ, et al. Hepatocyte growth factor-induced amelioration in chronic. Renal failure is associated with reduced expression of alpha-smooth muscle actin. Renal Fail. 2012;34:862–870. doi: 10.3109/0886022x.2012.687344.
   Google Scholar
• Shen Y-C, Yang X, Chen Q-X. Renal pathological changes in rat with 5/6 nephrectomy [J]. Shanghai Lab Anim Sci. 2005;1:006.
   Google Scholar
• Zhao G, Zhao H, Tu L, et al. Effects and mechanism of irbesartan on tubulointerstitial fibrosis in 5/6 nephrectomized rats. J Huazhong Univ Sci Technol [Med Sci]. 2010;30:48–54. Feb doi: 10.1007/s11596-010-0109-1.
   PubMedGoogle Scholar
• Ihle BU, Whitworth JA, Shahinfar S, et al. Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial. Am J Kidney Dis. 1996;27:489–495.
   PubMed Web of Science ®Google Scholar
• Hou FF, Zhang X, Zhang GH, et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med. 2006;354:131–140. Jan 12 doi: 10.1056/NEJMoa053107.
   PubMed Web of Science ®Google Scholar
• Wang HY, Wang YJ, Cui MJ, et al. Hepatocyte growth factor-induced amelioration in renal interstitial fibrosis is associated with reduced expression of alpha-smooth muscle actin and transforming growth factor-beta1. Indian J Biochem Biophys. 2011; 48:308–315.
   PubMed Web of Science ®Google Scholar
• Barata K, Yoshida M, Hokao R, et al. Sequential alterations in clinical biochemical indicators of renal function in 5/6 nephrectomized rats–basic study for renal toxicity using 5/6 nephrectomized rats. J Toxicol Sci. 1998;23:433–442.
   PubMedGoogle Scholar
• Wang HY, Yang LZ, Gu CM, et al. Pathological changes, TGF-beta1 expression, and the effects of hepatocyte growth factor in 5/6 nephrectomized rats. Renal Fail. 2014;36:393–399. doi: 10.3109/0886022x.2013.867797.
   PubMed Web of Science ®Google Scholar
• Reeves WB, Andreoli TE. Transforming growth factor beta contributes to progressive diabetic nephropathy. Proc Natl Acad Sci USA 2000;97:7667–7669.
   PubMed Web of Science ®Google Scholar
• Han DC, Isono M, Hoffman BB, et al. High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta. J Am Soc Nephrol 1999; 10:1891–1899.
   PubMed Web of Science ®Google Scholar
• Sato F, Narita I, Goto S, et al. Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy. Tissue Antigens. 2004;64:35–42. Jul doi: 10.1111/j.1399-0039.2004.00256.x.
   PubMedGoogle Scholar
• Rastaldi MP. Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis. J Nephrol. 2006; 19:407–412.
   PubMed Web of Science ®Google Scholar
• Masszi A, Fan L, Rosivall L, et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol. 2004;165:1955–1967.
   PubMed Web of Science ®Google Scholar
• Rekola S, Bergstrand A, Bucht H. Deterioration rate in hypertensive IgA nephropathy: comparison of a converting enzyme inhibitor and beta-blocking agents. Nephron 1991;59:57–60. doi: 10.1159/000186518.
   PubMed Web of Science ®Google Scholar
• Taal MW, Brenner BM. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int. 2000;57:1803–1817. doi: 10.1046/j.1523-1755.2000.00031.x.
   PubMed Web of Science ®Google Scholar
• Coppo R, Amore A, Gianoglio B, et al. Angiotensin II local hyperreactivity in the progression of IgA nephropathy. Am J Kidney Dis. 1993;21:593–602.
   PubMed Web of Science ®Google Scholar